Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds outbreak of Cipro web sites followed anthrax outbreak

13.09.2002


Web sites selling the prescription-only medication ciprofloxacin (also known by its brand name Cipro®) sprang up quickly following an anthrax outbreak in October 2001, according to a new study by researchers from the Case Western Reserve University (CWRU) School of Medicine. The study, published today in the American Journal of Medicine, also found that these Web sites provided poor quality information, had inadequate consumer safeguards, and charged high prices.



On Oct. 4, 2001, the U.S. Centers for Disease Control and Prevention reported the first case of an anthrax outbreak by mail. Immediately following the anthrax outbreak, numerous Web sites began selling ciprofloxacin, then the only U.S. Food and Drug Administration (FDA)-approved drug to treat anthrax exposure. The outbreak provided the research team with a unique opportunity to illustrate the general difficulties regulators have had with these so-called "Internet pharmacies" that sell prescription drugs directly to the general public.

The researchers compiled information on 59 Web sites selling ciprofloxacin without a prescription between Oct. 28 and Oct. 31, 2001. Twenty-three sites (39 percent) had been created during the two weeks following the Oct. 4, 2001 announcement of the anthrax outbreak. Within a month, 29 sites (49 percent) had discontinued ciprofloxacin sales.


"The host of Web sites we identified sprouted up within two weeks of the anthrax outbreak – one outbreak immediately following the other," said Alexander Tsai, a fourth-year CWRU medical student in the Dual Degree Program in Medicine and Health Services Research. "These online sales of prescription-only medications clearly do not involve any meaningful medical assessment, which is necessary when prescribing a potentially dangerous antibiotic like ciprofloxacin."

Most state medical practice acts stipulate that a physician must examine a patient before prescribing a medication. However, none of the Web sites in the CWRU study required the customer to mail or fax in a physician’s prescription. Forty-nine sites (81 percent) simply asked the customer to fill out an online questionnaire with minimal questions about the customer’s medical history and symptoms. The other eleven sites (19 percent) did not even require customers to fill out a medical questionnaire for purchase.

Tsai conducted this study with the help of Dr. Peter Lurie, deputy director of the Washington D.C.-based Public Citizen’s Health Research Group, and Dr. Ashwini Seghal, a nephrologist at MetroHealth Medical Center and an associate professor of medicine at CWRU. The researchers also had concerns about the quality of these Web sites. Seventeen of the 59 sites (29 percent) displayed no information about potential adverse effects, and 16 sites (27 percent) did not mention the danger of life-threatening allergic reactions if patients with a history of hypersensitivity to quinolone antibiotics (such as ciprofloxacin) use the drug. On eight sites (14 percent), the researchers documented false or misleading claims.

During the study period, state authorities brought enforcement actions against three of the Web sites in the CWRU study. Also in response to the Internet explosion of Web sites selling ciprofloxacin, the FDA ordered all private ciprofloxacin shipments arriving from overseas to be stopped at the border. Eleven of the 59 sites (19 percent) were based in foreign countries, while the rest were registered to U.S. addresses.

"The sale of prescription drugs on the Internet is both a federal and state issue, but neither has the resources or adequate legal authority to act quickly enough," said Lurie. "The problem is that feds have largely deferred to the states – but the states have not filled the regulatory vacuum."

Tsai said he was inspired to undertake the research project after studying the work of other researcher-activists. Sehgal teaches an "Activism and Medicine" elective class for CWRU medical students. More information about this class can be found at http://home.cwru.edu/activism

George Stamatis | EurekAlert!
Further information:
http://www.cwru.edu/
http://home.cwru.edu/activism

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>